ADVERTISEMENT
News
Efficacy of Autologous MSCs for Lower Limb Ulcers
04/10/2024
A 40-patient Phase II RCT will evaluate the safety and efficacy of autologous MSC therapy for lower limb ulcers in patients w/ critical limb ischemia. The primary outcome is amputation at 120 days and ulcer healing up to 120 days. Estimated study completion is Dec 2027. clinicaltrials.gov